Emmes completed the acquisition of VaxTRIALS.

Emmes, a full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, completed the acquisition of VaxTRIALS, a specialized Clinical Research Organization. Financial terms were not disclosed. “Both our companies have built enduring customer relationships and a legacy of service in vaccine and infectious disease research. I am proud that we have made both people and cultural development a priority, including hiring and developing employees who care deeply about making a difference in public health," Dr. José Jimeno, VaxTRIALS CEO.